Maternal and Fetal Outcomes in Early-Onset Severe Preeclampsia (Code-T0255)

Introduction: Early-onset severe preeclampsia (EOSPE), occurring before 34 weeks of gestation, is a life-threatening hypertensive disorder of pregnancy associated with significant maternal and fetal morbidity and mortality. Timely diagnosis and management are crucial to improving outcomes. This study aims to evaluate the maternal and fetal outcomes in patients diagnosed with EOSPE.

Aims and Objectives:

1) To study the maternal and fetal outcome in early onset severe preeclampsia.

2) To note the variable factors associated with maternal and fetal morbidity and mortality.

Methods: This prospective observational study will be conducted at a tertiary care hospital. Pregnant women diagnosed with EOSPE based on clinical and laboratory criteria will be included. Maternal parameters such as blood pressure, organ dysfunction, need for intensive care, and maternal mortality will be recorded. Fetal outcomes, including gestational age at delivery, birth weight, neonatal intensive care unit (NICU) admission, and perinatal mortality, will be analyzed. Statistical analysis will be performed using SPSS software to determine correlations.

Results: The study will provide insights into the incidence of maternal complications such as eclampsia, HELLP syndrome, and placental abruption, as well as neonatal outcomes like prematurity, low birth weight, and perinatal mortality.

Conclusion: Understanding the impact of EOSPE on maternal and fetal health can guide early interventions and improve clinical management strategies to reduce adverse outcomes.

Keywords: Early-Onset Severe Preeclampsia, Maternal Morbidity, Fetal Outcomes, Hypertensive Disorders, Perinatal Mortality, Pregnancy Complications.